TRAWS PHARMA, INC.

Profile

Company Names

TRAWS PHARMA, INC.
ONCONOVA THERAPEUTICS INC
ONCONOVA THERAPEUTICS, INC.

Addresses

12 PENNS TRAIL, NEWTOWN, PA 18940

375 PHEASANT RUN, NEWTOWN, PA 18940

Phone Numbers

2677593680
267-759-3681

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$124,610,792.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-04-01 
$14,000,000.00 
$14,000,000.00 
$0.00 
 
7
2019-05-10 
$500,000.00 
$2,000,000.00 
$1,500,000.00 
Equity 
6
2018-04-05 
$1,250,000.00 
$1,250,000.00 
$0.00 
Equity 
5
2015-10-08 
$1,500,000.00 
$16,500,000.00 
$15,000,000.00 
Equity 
4
2012-07-27 
$49,999,999.00 
$49,999,999.00 
$0.00 
Equity 
3
2012-04-27 
$26,444,316.00 
$30,000,000.00 
$3,555,684.00 
Equity 
2
2010-09-21 
$11,690,190.00 
$20,000,000.00 
$8,309,810.00 
Equity 
1
2009-05-12 
$19,226,287.00 
$26,309,969.00 
$7,083,682.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AJAY 
 
BANSAL 
EXECUTIVE OFFICER
DR. FRESH HOLDINGS, LLC   |  ONCONOVA THERAPEUTICS, INC.   |  VIEWRAY, INC.
HENRY 
S 
BIENEN 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
HENRY 
S. 
BIENEN 
DIRECTOR
GROSVENOR REGISTERED MULTI-STRATEGY MASTER FUND, LLC   |  GROSVENOR REGISTERED MULTI-STRATEGY FUND (TE), LLC   |  GROSVENOR REGISTERED MULTI-STRATEGY FUND (TI 2), LLC   |  GROSVENOR REGISTERED MULTI-STRATEGY FUND (TI 1), LLC   |  ONCONOVA THERAPEUTICS, INC.   |  RYAN SPECIALTY GROUP, LLC
HENRY 
S. 
BIENEN, PH.D. 
DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.
HENRY 
B. 
BINEN 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
WERNER 
 
CAUTREELS 
DIRECTOR, EXECUTIVE OFFICER
SOLVAY SA /FI   |  SELECTA BIOSCIENCES INC   |  SERES HEALTH, INC.   |  THIRD POLE, INC.   |  TRAWS PHARMA, INC.
TRAFFORD 
 
CLARKE 
DIRECTOR
TRAWS PHARMA, INC.
IAN 
 
DUKES 
DIRECTOR
TRAWS PHARMA, INC.
STEVEN 
 
FRUCHTMAN 
EXECUTIVE OFFICER
TRAWS PHARMA, INC.
STEVEN 
M. 
FRUCHTMAN 
EXECUTIVE OFFICER, DIRECTOR
ONCONOVA THERAPEUTICS, INC.
JEROME 
E. 
GROOPMAN 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
MARK 
 
GUERIN 
EXECUTIVE OFFICER
TRAWS PHARMA, INC.
MARK 
P. 
GUERIN 
EXECUTIVE OFFICER
ONCONOVA THERAPEUTICS, INC.
MICHAEL 
 
HOFFMAN 
DIRECTOR
THERMASOURCE LLC   |  PATTERN ENERGY GROUP HOLDINGS LP   |  BRAZIL POTASH CORP.   |  CROCODILE GOLD, INC.   |  CROCODILE GOLD CORP.   |  MBA POLYMERS INC   |  ONCONOVA THERAPEUTICS, INC.   |  LARGO RESOURCES LTD.   |  TREVALI MINING CORP   |  QR PHARMA, INC.   |  DATIPHY INC.   |  EASTMAIN RESOURCES INC   |  FVP OPPORTUNITY FUND HOLDINGS, LLC   |  EXCELSIOR VENTURES FUND I LP   |  FURY GOLD MINES LTD   |  METALMARK FIDO CONTINUATION VEHICLE, L.P.   |  SILVER X MINING CORP.   |  GATHER VOICES, INC.   |  WISDOM GAMING, INC.   |  ANNOVIS BIO, INC.   |  NEWBOUND VENTURES FUND II LP   |  LUNR CAPITAL, INC.
MICHAEL 
B. 
HOFFMAN 
DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.
RAMESH 
 
KUMAR 
EXECUTIVE OFFICER, DIRECTOR
ZAKIPOINT HEALTH, INC.   |  ONCONOVA THERAPEUTICS, INC.   |  OCUGEN, INC.
RAMESH 
 
KUMAR, PH.D 
EXECUTIVE OFFICER, DIRECTOR
ONCONOVA THERAPEUTICS, INC.
RAMESH 
 
KUMAR, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.
SHEKHAR 
 
KUNDUR 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
MANOJ 
 
MANIAR 
EXECUTIVE OFFICER
ONCONOVA THERAPEUTICS, INC.
JAMES 
 
MARINO 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.   |  ALDER SOMSERSET IV LLC   |  TRAWS PHARMA, INC.
JAMES 
J. 
MARINO 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
THOMAS 
 
MCKEARN 
EXECUTIVE OFFICER
ADVAXIS, INC.   |  ONCONOVA THERAPEUTICS, INC.
VIREN 
 
MEHTA 
DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.   |  COFERON, INC.   |  BLINKBIO, INC.
ABRAHAM 
N. 
OLER 
EXECUTIVE OFFICER
ONCONOVA THERAPEUTICS, INC.
PANKAJ 
 
PATEL 
DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.   |  ASHFORD HOTEL OF THE TRIAD, LLC   |  EASIC CORP   |  VALUATION RESEARCH CORP   |  USHUR, INC.   |  IOTIUM, INC.   |  KMESH, INC.   |  UNIPHORE TECHNOLOGIES INC.   |  PRIVORO HOLDINGS, INC.   |  G2 DEVELOPMENTS OF MICHIGAN LLC   |  VERSA NETWORKS, INC.
DAVID 
 
PAUZA 
EXECUTIVE OFFICER
TRAWS PHARMA, INC.
K 
 
RAVINDRA 
DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.
K. 
 
RAVINDRA 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
E. PREMKUMAR 
 
REDDY 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
PREMKUMAR 
 
REDDY 
DIRECTOR
ONCONOVA THERAPEUTICS, INC.
E. PREMKUMAR 
 
REDDY, PH.D 
EXECUTIVE OFFICER, DIRECTOR
ONCONOVA THERAPEUTICS, INC.
E. PREMKUMAR 
 
REDDY, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.
ROBERT 
 
REDFIELD 
EXECUTIVE OFFICER
TRAWS PHARMA, INC.
NIKOLAY 
 
SAVCHUK 
DIRECTOR, EXECUTIVE OFFICER
TRAWS PHARMA, INC.   |  BRENIG THERAPEUTICS, INC.   |  LOMOND THERAPEUTICS HOLDINGS, INC.
M. 
THERESA 
SHOEMAKER 
DIRECTOR
TRAWS PHARMA, INC.
JACK 
E. 
STOVER 
DIRECTOR
INTERPACE DIAGNOSTICS GROUP, INC.   |  ONCONOVA THERAPEUTICS, INC.   |  INTERPACE BIOSCIENCES, INC.   |  TRAWS PHARMA, INC.
ANNE 
M. 
VANLENT 
DIRECTOR
OCERA THERAPEUTICS, INC.   |  ONCONOVA THERAPEUTICS, INC.
ALAN 
R. 
WILLIAMSON 
DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.
RICHARD 
C. 
WOODMAN 
EXECUTIVE OFFICER
ONCONOVA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-04-01 
2019-06-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2019-05-10 
2018-06-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2018-04-05 
2015-10-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-10-08 
2012-08-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-27 
2012-07-26
D/A
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2012-04-27 
2012-05-10
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2012-04-27 
2011-01-05
D/A
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2010-09-21 
2010-10-04
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2010-09-21 
2010-03-04
D/A
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2009-05-12 
2009-05-26
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2009-05-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
FINALIS SECURITIES LLC
305908
NONE
NONE
LUCAS ADVISORS LLC D/B/A KYBORA EMERGING MARKETS
NONE
LUCAS ADVISORS LLC D/B/A KYBORA EMERGING MARKETS
NONE
NONE
NONE
AQUILO PARTNERS, L.P.
114909